We are live on
!
Find out more
Zurich Cantonal Bank Portfolio holdings
AUM
$46B
1-Year Est. Return
27.59%
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+27.59%
3 Year Est. Return
+97.89%
5 Year Est. Return
+132.69%
10 Year Est. Return
+500.34%
AUM
$40.9B
AUM Growth
+$6.08B
(+17%)
Cap. Flow
+$2.16B
Cap. Flow
% of AUM
5.29%
Top 10 Holdings %
Top 10 Hldgs %
33.91%
Holding
2,656
New
37
Increased
1,264
Reduced
635
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMRZ
Amrize Ltd
AMRZ
|
+$459M |
| 2 |
Apple
AAPL
|
+$167M |
| 3 |
Microsoft
MSFT
|
+$148M |
| 4 |
NVIDIA
NVDA
|
+$141M |
| 5 |
UBS Group
UBS
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$104M |
| 2 |
CME Group
CME
|
+$92.2M |
| 3 |
Procter & Gamble
PG
|
+$67.1M |
| 4 |
Verizon
VZ
|
+$53.3M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$51.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.17% |
| 2 | Financials | 17.35% |
| 3 | Healthcare | 10.51% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Industrials | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JKS
2426
JinkoSolar
JKS
$893M
| $15K | ﹤0.01% |
709
-63
| -8% | -$1.15K |
|
2427
British American Tobacco
BTI
$125B
| $14.7K | ﹤0.01% |
311
| – | – |
|
2428
American Public Education
APEI
$929M
| $14.7K | ﹤0.01% |
481
+142
| +42% | +$3.75K |
|
2429
Ascendis Pharma A/S
ASND
$16.7B
| $14.3K | ﹤0.01% |
83
-14
| -14% | -$2.28K |
|
2430
Trevi Therapeutics
TRVI
$2.65B
| $14.1K | ﹤0.01% |
2,576
-305
| -11% | -$1.9K |
|
2431
Mesa Laboratories
MLAB
$568M
| $13.9K | ﹤0.01% |
148
| – | – |
|
2432
Tevogen Inc. Common Stock
TVGN
$26.5M
| $13.8K | ﹤0.01% |
220
-24
| -10% | -$1.37K |
|
2433
Theravance Biopharma
TBPH
$878M
| $13.7K | ﹤0.01% |
1,246
-136
| -10% | -$1.32K |
|
2434
Hyster-Yale Materials Handling
HY
$665M
| $13.4K | ﹤0.01% |
336
| – | – |
|
2435
Summit Therapeutics
SMMT
$11.3B
| $13.4K | ﹤0.01% |
628
-108
| -15% | -$2.46K |
|
2436
AbCellera Biologics
ABCL
$2.7B
| $13K | ﹤0.01% |
3,789
-416
| -10% | -$1.04K |
|
2437
Rigel Pharmaceuticals
RIGL
$746M
| $12.4K | ﹤0.01% |
663
-73
| -10% | -$1.38K |
|
|
DQ
2438
Daqo New Energy
DQ
$988M
| $12.2K | ﹤0.01% |
805
-70
| -8% | -$994 |
|
2439
MeiraGTx Holdings
MGTX
$1.2B
| $12K | ﹤0.01% |
1,841
-204
| -10% | -$1.21K |
|
2440
Pacific Biosciences
PACB
$363M
| $12K | ﹤0.01% |
9,672
-74,657
| -89% | -$86.2K |
|
2441
Personalis
PSNL
$1.51B
| $12K | ﹤0.01% |
1,827
-203
| -10% | -$942 |
|
2442
Zevra Therapeutics
ZVRA
$678M
| $11.6K | ﹤0.01% |
1,319
-145
| -10% | -$1.18K |
|
|
LENZ
2443
LENZ Therapeutics
LENZ
$169M
| $11.6K | ﹤0.01% |
396
-64
| -14% | -$1.74K |
|
2444
Regenxbio
RGNX
$702M
| $11.5K | ﹤0.01% |
1,397
-156
| -10% | -$1.31K |
|
|
LKFT
2445
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
| $11.4K | ﹤0.01% |
409
-46
| -10% | -$1.23K |
|
2446
Inhibrx
INBX
$1.3B
| $10.5K | ﹤0.01% |
737
-87
| -11% | -$1.13K |
|
2447
AstraZeneca
AZN
$249B
| $10.5K | ﹤0.01% |
75
| – | – |
|
2448
argenx
ARGX
$54.4B
| $10.5K | ﹤0.01% |
19
-2
| -10% | -$1.16K |
|
2449
GlobalFoundries
GFS
$29.9B
| $10.2K | ﹤0.01% |
266
-76
| -22% | -$2.75K |
|
2450
Limoneira
LMNR
$251M
| $9.28K | ﹤0.01% |
593
+22
| +4% | +$348 |
|
Similar funds
LP
TI
Zurich Cantonal Bank's Q2 2025 Portfolio in Review
As of Q2 2025, Zurich Cantonal Bank held 2,656 positions worth $40.9B, up 17% from $34.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Zurich Cantonal Bank deployed $2.16B of net new capital in Q2 2025, opening 37 new positions and adding to 1,264 existing holdings. Its largest new stake was Amrize Ltd: 9,097,290 shares worth $452M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $104M trimmed.
- Zurich Cantonal Bank's largest Q2 2025 buy was Amrize Ltd: 9,097,290 shares worth $452M.
- Zurich Cantonal Bank added most to Apple in Q2 2025, an estimated $167M increase.
- Zurich Cantonal Bank's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $104M.
- Zurich Cantonal Bank fully exited Discover Financial Services in Q2 2025, selling an estimated $51.8M.
- Zurich Cantonal Bank's ten largest holdings make up 34% of its $40.9B portfolio in Q2 2025.
- Zurich Cantonal Bank opened 37 new positions and closed 96 in Q2 2025.
- Zurich Cantonal Bank's portfolio value rose 17% quarter-over-quarter to $40.9B.
Based on Zurich Cantonal Bank's 13F filing for Q2 2025, filed 7 Aug 2025.